home / stock / cntb / cntb news


CNTB News and Press, Connect Biopharma Holdings Limited From 11/18/21

Stock Information

Company Name: Connect Biopharma Holdings Limited
Stock Symbol: CNTB
Market: NASDAQ
Website: connectbiopharm.com

Menu

CNTB CNTB Quote CNTB Short CNTB News CNTB Articles CNTB Message Board
Get CNTB Alerts

News, Short Squeeze, Breakout and More Instantly...

CNTB - Connect Biopharma Reports Positive Top-Line Results from the Global Phase 2 Clinical Trial of CBP-201 in Patients with Moderate-to-Severe Atopic Dermatitis

Primary endpoint met with all three CBP-201 arms achieving significant improvements Significant improvements also reported for key secondary endpoints including other measures of skin clearance and itch with CBP-201 300mg every two weeks ( Q2W) arm The Company intend...

CNTB - Connect Biopharma to Participate at Upcoming Conferences

SAN DIEGO, CA and TAICANG, SUZHOU, China, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients wi...

CNTB - Connect Biopharma to Participate at the Jefferies Virtual China Biotech Summit

SAN DIEGO, CA and TAICANG, SUZHOU, China, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inf...

CNTB - SESN, BWEN and CETX among mid-day movers

Gainers: Grove (NASDAQ:GRVI) +62%. NRx Pharmaceuticals (NASDAQ:NRXP) +35%. Connect Biopharma (NASDAQ:CNTB) +23%. Huttig Building Products (NASDAQ:HBP) +20%. KORE (NYSE:KORE) +20%. DarioHealth (NASDAQ:DRIO) +19%. Broadwind (NASDAQ:BWEN) +19%. Cemtrex (NASDAQ:CETX) +17%. Annovis (NYSE:ANVS) +17...

CNTB - Grove, NRx Pharmaceuticals leads healthcare gainers; Jasper Therapeutics, PLx Pharma among major losers

Gainers: Grove (NASDAQ:GRVI) +63%, NRx Pharmaceuticals (NASDAQ:NRXP) +34%, DarioHealth (NASDAQ:DRIO) +22%, Connect Biopharma (NASDAQ:CNTB) +21%, Annovis Bio (NYSE:ANVS) +15%. Losers: Jasper Therapeutics (NASDAQ:JSPR) -20%, PLx Pharma (NASDAQ:P...

CNTB - Arena Pharmaceuticals: A Speculative Buy To Play The Upcoming Etrasimod's Data-Readout

After the recent FDA black box warning of JAKi, Arena Pharmaceuticals' share price has rallied recovering some of its 2021 losses. In this article, Etrasimod's ulcerative colitis phase 2 data will be analyzed and explain what our views for the S1P-R class moving forward. Arena Pha...

CNTB - ZIVO Bioscience, Edesa Biotech leads healthcare gainers; BeyondSpring, Protagonist Therapeutics among major losers

Gainers: ZIVO Bioscience (NASDAQ:ZIVO) +155%, Edesa Biotech (NASDAQ:EDSA) +34%, Atea Pharmaceuticals (NASDAQ:AVIR) +20%, Synlogic (NASDAQ:SYBX) +13%, Viveve Medical (NASDAQ:VIVE) +9%. Losers: BeyondSpring (NASDAQ:BYSI) -22%, Protagonist Therap...

CNTB - Wall Street Breakfast: The Week Ahead (Podcast)

You can read full article here. For further details see: Wall Street Breakfast: The Week Ahead (Podcast)

CNTB - Catalyst watch for next week: Apple, Zoom Video, Palo Alto Networks in the spotlight; OPEC update

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

CNTB - Connect Biopharma Announces First Subject Dosed in Phase 2 Trial Evaluating CBP-201 in Adult Patients with Chronic Rhinosinusitis with Nasal Polyps

SAN DIEGO, CA and TAICANG, SUZHOU, China, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic in...

Previous 10 Next 10